XML 221 R32.htm IDEA: XBRL DOCUMENT
v3.25.2

Statements of Operations-Additional Information (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2025
Statements of Operations-Additional Information |
Schedule of revenues disaggregated by major product category and geographic region | Net Sales by Product Type
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | ​ | ​ | ​ | ​
For the Year Ended June 30 | ​ | 2025 | ​ | 2024 | ​ | 2023
Animal Health | ​ | ​ |  |  | ​ |  | ​ | ​ | ​
MFAs and other | ​ | $ | 646,354 | ​ | $ | 420,959 | ​ | $ | 387,349
Nutritional specialties | ​ |  | 179,289 | ​ |  | 164,671 | ​ | ​ | 172,504
Vaccines | ​ |  | 137,153 | ​ |  | 120,852 | ​ | ​ | 99,998
Total Animal Health | ​ | $ | 962,796 | ​ | $ | 706,482 | ​ | $ | 659,851
Mineral Nutrition | ​ |  | 253,240 | ​ |  | 243,663 | ​ | ​ | 242,656
Performance Products | ​ |  | 80,179 | ​ |  | 67,534 | ​ | ​ | 75,382
Total | ​ | $ | 1,296,215 | ​ | $ | 1,017,679 | ​ | $ | 977,889
​ Net Sales by Region
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
For the Year Ended June 30 | ​ | 2025 |  | 2024 |  | 2023
United States | ​ | $ | 739,919 | ​ | $ | 584,763 | ​ | $ | 578,773
Latin America and Canada | ​ |  | 298,649 | ​ |  | 247,705 | ​ | ​ | 219,846
Europe, Middle East and Africa | ​ |  | 160,232 | ​ |  | 121,977 | ​ | ​ | 117,815
Asia Pacific | ​ |  | 97,415 | ​ |  | 63,234 | ​ | ​ | 61,455
Total | ​ | $ | 1,296,215 | ​ | $ | 1,017,679 | ​ | $ | 977,889
Schedule of interest expense, net | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
For the Year Ended June 30 | ​ | 2025 |  | 2024 |  | 2023
Interest expense, net | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Credit Facilities | ​ | $ | 32,779 | ​ | $ | 20,646 | ​ | $ | 17,302
2022 Term loan | ​ | ​ | 12 | ​ | ​ | 862 | ​ | ​ | 589
Amortization of debt issuance costs | ​ |  | 2,015 | ​ |  | 1,040 | ​ |  | 727
Refinancing expense | ​ | ​ | 1,960 | ​ | ​ | — | ​ | ​ | —
Other | ​ |  | 458 | ​ |  | 462 | ​ |  | 58
Interest expense | ​ |  | 37,224 | ​ |  | 23,010 | ​ |  | 18,676
Interest income | ​ |  | (2,622) | ​ |  | (4,474) | ​ |  | (3,355)
​ | ​ | $ | 34,602 | ​ | $ | 18,536 | ​ | $ | 15,321
Schedule of depreciation and amortization | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
For the Year Ended June 30 |  | 2025 |  | 2024 |  | 2023
Depreciation and amortization | ​ |  | ​ | ​ |  | ​ | ​ |  |
Depreciation of property, plant and equipment | ​ | $ | 37,762 | ​ | $ | 26,517 | ​ | $ | 24,316
Amortization of intangible assets | ​ |  | 7,843 | ​ |  | 9,661 | ​ |  | 9,696
​ | ​ | $ | 45,605 | ​ | $ | 36,178 | ​ | $ | 34,012
Schedule of amortization of intangible assets | ​
​ | ​ | ​ | ​
For the Years Ending June 30 |  | ​ |
2026 | ​ | $ | 6,789
2027 | ​ |  | 6,416
2028 | ​ |  | 6,205
2029 | ​ |  | 6,205
2030 | ​ |  | 4,805
Thereafter | ​ |  | 6,048
Total | ​ | $ | 36,469
Schedule of research and development expense | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
For the Year Ended June 30 |  | 2025 |  | 2024 |  | 2023
Research and development expense | ​ | $ | 23,726 | ​ | $ | 29,194 | ​ | $ | 24,395

X
- Definition Tabular disclosure of depreciation and amortization. + References No definition available. + Details
Name: | pahc_ScheduleOfDepreciationAndAmortizationTableTextBlock
Namespace Prefix: | pahc_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of interest expense, net. + References No definition available. + Details
Name: | pahc_ScheduleOfInterestExpenseNetTableTextBlock
Namespace Prefix: | pahc_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of research and development expense. + References No definition available. + Details
Name: | pahc_ScheduleOfResearchAndDevelopmentExpenseTableTextBlock
Namespace Prefix: | pahc_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_IncomeStatementRelatedDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name Accounting Standards Codification -Section 55 -Paragraph 40 -SubTopic 30 -Topic 350 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2 + Details
Name: | us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration